Statement of Organization, Functions, and Delegations of Authority, 1416-1417 [2015-00146]
Download as PDF
<![CDATA[
1416
Federal Register / Vol. 80, No. 6 / Friday, January 9, 2015 / Notices
Dated: December 24, 2014.
Myles Vaughan,
NEPA Program Manager, Facilities
Management & Services Programs Division,
U.S. GSA, Mid-Atlantic Region.
[FR Doc. 2014–30791 Filed 1–8–15; 8:45 am]
BILLING CODE 6820–89–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2015–0001]
Proposed Revised Vaccine Information
Materials for Multiple Pediatric
Vaccines (‘‘Your Baby’s First
Vaccines’’)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
Under the National
Childhood Vaccine Injury Act (NCVIA)
(42 U.S.C. 300aa–26), the Centers for
Disease Control and Prevention (CDC)
within the Department of Health and
Human Services (HHS) develops
vaccine information materials that all
health care providers are required to
give to patients/parents prior to
administration of specific vaccines.
HHS/CDC seeks written comment on the
proposed updated vaccine information
statement for multiple pediatric
vaccines.
SUMMARY:
Written comments must be
received on or before March 10, 2015.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2015–
0001, by any of the following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Written comments should be
addressed to Suzanne Johnson-DeLeon
(msj1@cdc.gov), National Center for
Immunization and Respiratory Diseases,
Centers for Disease Control and
Prevention, Mailstop A–19, 1600 Clifton
Road NE., Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
docket number. All relevant comments
received will be posted without change
to https://www.regulations.gov, including
any personal information provided. For
access to the docket to read background
documents or comments received, go to
https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT: Skip
Wolfe (crw4@cdc.gov), National Center
for Immunization and Respiratory
Diseases, Centers for Disease Control
rljohnson on DSK3VPTVN1PROD with NOTICES
DATES:
VerDate Sep<11>2014
14:56 Jan 08, 2015
Jkt 235001
and Prevention, Mailstop A–19, 1600
Clifton Road NE., Atlanta, Georgia
30329.
The
National Childhood Vaccine Injury Act
of 1986 (Pub. L. 99–660), as amended by
section 708 of Public Law 103–183,
added section 2126 to the Public Health
Service Act. Section 2126, codified at 42
U.S.C. 300aa–26, requires the Secretary
of Health and Human Services to
develop and disseminate vaccine
information materials for distribution by
all health care providers in the United
States to any patient (or to the parent or
legal representative in the case of a
child) receiving vaccines covered under
the National Vaccine Injury
Compensation Program (VICP).
Development and revision of the
vaccine information materials, also
known as Vaccine Information
Statements (VIS), have been delegated
by the Secretary to the Centers for
Disease Control and Prevention (CDC).
Section 2126 requires that the materials
be developed, or revised, after notice to
the public, with a 60-day comment
period, and in consultation with the
Advisory Commission on Childhood
Vaccines, appropriate health care
provider and parent organizations, and
the Food and Drug Administration. The
law also requires that the information
contained in the materials be based on
available data and information, be
presented in understandable terms, and
include:
(1) A concise description of the
benefits of the vaccine,
(2) A concise description of the risks
associated with the vaccine,
(3) A statement of the availability of
the National Vaccine Injury
Compensation Program, and
(4) Such other relevant information as
may be determined by the Secretary.
The vaccines initially covered under
the National Vaccine Injury
Compensation Program were diphtheria,
tetanus, pertussis, measles, mumps,
rubella and poliomyelitis vaccines.
Since April 15, 1992, any health care
provider in the United States who
intends to administer one of these
covered vaccines is required to provide
copies of the relevant vaccine
information materials prior to
administration of any of these vaccines.
Since then, the following vaccines have
been added to the National Vaccine
Injury Compensation Program, requiring
use of vaccine information materials for
them as well: Hepatitis B, Haemophilus
influenzae type b (Hib), varicella
(chickenpox), pneumococcal conjugate,
rotavirus, hepatitis A, meningococcal,
human papillomavirus (HPV), and
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
seasonal influenza vaccines.
Instructions for use of the vaccine
information materials are found on the
CDC Web site at: https://www.cdc.gov/
vaccines/hcp/vis/. Copies of
the Vaccine Information Statements are
found in the docket at
www.regulations.gov (Docket CDC–
2015–0001) under ‘‘Supporting and
Related Materials.’’
HHS/CDC is proposing an updated
version of the multiple pediatric
vaccines (‘‘Your Baby’s First Vaccines’’)
vaccine information statement.
The vaccine information materials
referenced in this notice are being
developed in consultation with the
Advisory Commission on Childhood
Vaccines, the Food and Drug
Administration, and parent and health
care provider groups.
We invite written comment on the
proposed vaccine information material
entitled ‘‘Your Baby’s First Vaccines:
What You Need to Know.’’ A copy of
the proposed vaccine information
statement is available at
www.regulations.gov (see Docket ID
CDC–2015–0001). Comments submitted
will be considered in finalizing these
materials. When the final materials are
published in the Federal Register, the
notice will include an effective date for
their mandatory use.
Dated: January 5, 2015.
Ron A. Otten,
Acting Deputy Associate Director for Science,
Centers for Disease Control and Prevention.
[FR Doc. 2015–00171 Filed 1–8–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 79 FR 21760–21763,
dated April 17, 2014) is amended to
reflect the reorganization of the Office of
Safety, Security and Asset Management.
Section C–B, Organization and
Functions, is hereby amended as
follows:
Delete items (1), (2) and (3) of the
functional statement for the Office of
Operations (CAJ13), Office of the
E:\FR\FM\09JAN1.SGM
09JAN1
Federal Register / Vol. 80, No. 6 / Friday, January 9, 2015 / Notices
Director (CAJS1), Office of the Safety,
Security and Asset Management (CAJS),
and renumber the remaining items
accordingly.
Delete item (7) of the functional
statement for the Physical Security
Laboratory and Technical Branch
(CAJSEB), Security Services Office
(CAJSE), Office of the Safety, Security
and Asset Management (CAJS), and
renumber remaining items accordingly.
Delete item (11) of the functional
statement for the Physical Security
Operations Branch (CAJSEC), Security
Services Office (CAJSE), Office of the
Safety, Security and Asset Management
(CAJS), and renumber remaining items
accordingly.
After the mission statement for the
Security Services Office (CAJSE), insert
the following:
Internal Emergency Management
Branch (CAJSEE). To lead a
comprehensive internal emergency
management program that efficiently
coordinates CDC resources to, first and
foremost, protect lives, then to safeguard
the environment and property through
mitigation, preparedness training,
response, continuity and recovery from
all natural, man-made and technological
hazards that may impact CDC facilities:
(1) Implements, maintains, and updates
CDC’s Occupant Emergency Plan/
Program (OEP); (2) conducts and
evaluates annual tabletop, functional,
and full-scale exercises for all CDC
facilities with Designated Officials and
Occupant Emergency Organizations
(OEO); (3) recommends future
emergency management and emergency
response-related programs, policies,
and/or procedures; (4) provides
leadership and coordination in planning
and implementation for internal
emergencies; and (5) provides
leadership and coordination in planning
and implementation for internal
emergency incidents affecting the CDC
facilities, including incident response
and support.
James D. Seligman,
Acting Chief Operating Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2015–00146 Filed 1–8–15; 8:45 am]
BILLING CODE 4160–18–P
rljohnson on DSK3VPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
VerDate Sep<11>2014
14:56 Jan 08, 2015
Jkt 235001
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 79 FR 32739–32740,
dated June 7, 2014) is amended to
reflect the reorganization of the Global
Immunization Division within the
Center for Global Health.
Section C–B, Organization and
Functions, is hereby amended as
follows:
Delete in its entirety the title and the
mission and function statements for the
Global Immunization Division (CWK)
and insert the following:
Global Immunization Division (CWK).
The Global Immunization Division
(GID) protects the health of Americans
and global citizens by preventing
disease, disability, and death worldwide
from vaccine-preventable diseases. In
carrying out its mission, GID: (1)
Provides national leadership and
coordination of the Center for Global
Health (CGH) efforts to eradicate polio;
eliminate measles and rubella in World
Health Organization (WHO) regions;
strengthens global surveillance to
prevent, detect, and respond to vaccine
preventable diseases; strengthens
routine immunization programs;
introduces new and under-utilized
vaccines; and promotes safe injection
practices in collaboration with
international organizations and CDC
Centers/Institute/Offices (CIOs); (2)
provides technical expertise to global
partners—WHO, United Nations
International Children’s Emergency
Fund (UNICEF), Global Alliance for
Vaccine Immunization (GAVI), and the
Bill and Melinda Gates Foundation
(BMGF)—involved in global
immunization activities and participates
in international advisory group
meetings on immunization issues; (3)
ensures provision of technical expertise
on evidence-based research, strategies,
and policy at global and country levels
in collaboration with multilateral and
bilateral partners; (4) collaborates with
other countries and administers grants
to WHO, Pan American Health
Organization (PAHO), UNICEF, and
other international partners and
advocacy groups as appropriate for the
provision of technical, programmatic,
and laboratory support, and vaccine
procurement for initiatives to support
global immunization targets; (5)
improves surveillance for polio,
measles, rubella, and other vaccine
preventable diseases by working with
individual countries and the WHO
regional offices to improve surveillance
and to collaborate with groups within
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
1417
and outside CDC to expand
environmental surveillance; (6) achieves
global immunization targets by
supporting the strengthening of the
implementation of national
immunization policies; (7) strengthens
appropriate vaccination policy
development and implementation,
identifies barriers to vaccine acceptance,
and develops communication strategies
to promote vaccine uptake and disease
reduction; (8) develops strategies to
improve the technical skills and
problem-solving abilities of program
managers and health care workers in
other countries; (9) prepares
immunization articles based on findings
for publication in international
professional journals and for
presentation at international
conferences; and (10) provides technical
and operational leadership for CDC’s
activities in support of the initiatives.
Office of the Director (CWK1). (1)
Provides leadership, management, and
oversight for all division activities
including administrative, budget,
finance, research, workforce
development, management and
operations; (2) assists leadership in the
formulation and defense of GID budget
requests, and monitors and seeks
strategies to mitigate division risks; (3)
provides coordination and oversight of
the division’s personnel actions
including liaison with CGH and CDC’s
human resource office; (4) provides
oversight for workforce planning,
recruitment, deployment, field staff
support, professional development, and
monitoring and evaluation; (5) develops
and promotes partnerships with other
organizations to support global
immunization activities and works
closely with partners in academia; (6)
liaises and coordinates with other CDC
offices engaged in global immunization
activities; (7) provides leadership and
oversight for scientific and
programmatic activities related to the
implementation of GID’s objectives and
ensures that the research and economic
portfolios are integrated across the
branches and with field activities; (8)
identifies program policy priorities
through strategic planning and other
processes as appropriate; (9) clears all
scientific publications from the division
working in close collaboration with
management of GID; (10) provides
coordination of the division’s
communications activities including
liaison with other CDC communications
offices and those of our partner
agencies; (11) represents CDC, CGH, and
the division at global and national
meetings and other fora for global
immunization activities; (12) provides
E:\FR\FM\09JAN1.SGM
09JAN1
]]>Agencies
[Federal Register Volume 80, Number 6 (Friday, January 9, 2015)]
[Notices]
[Pages 1416-1417]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-00146]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Statement of Organization, Functions, and Delegations of
Authority
Part C (Centers for Disease Control and Prevention) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (45 FR 67772-76, dated
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as
amended most recently at 79 FR 21760-21763, dated April 17, 2014) is
amended to reflect the reorganization of the Office of Safety, Security
and Asset Management.
Section C-B, Organization and Functions, is hereby amended as
follows:
Delete items (1), (2) and (3) of the functional statement for the
Office of Operations (CAJ13), Office of the
[[Page 1417]]
Director (CAJS1), Office of the Safety, Security and Asset Management
(CAJS), and renumber the remaining items accordingly.
Delete item (7) of the functional statement for the Physical
Security Laboratory and Technical Branch (CAJSEB), Security Services
Office (CAJSE), Office of the Safety, Security and Asset Management
(CAJS), and renumber remaining items accordingly.
Delete item (11) of the functional statement for the Physical
Security Operations Branch (CAJSEC), Security Services Office (CAJSE),
Office of the Safety, Security and Asset Management (CAJS), and
renumber remaining items accordingly.
After the mission statement for the Security Services Office
(CAJSE), insert the following:
Internal Emergency Management Branch (CAJSEE). To lead a
comprehensive internal emergency management program that efficiently
coordinates CDC resources to, first and foremost, protect lives, then
to safeguard the environment and property through mitigation,
preparedness training, response, continuity and recovery from all
natural, man-made and technological hazards that may impact CDC
facilities: (1) Implements, maintains, and updates CDC's Occupant
Emergency Plan/Program (OEP); (2) conducts and evaluates annual
tabletop, functional, and full-scale exercises for all CDC facilities
with Designated Officials and Occupant Emergency Organizations (OEO);
(3) recommends future emergency management and emergency response-
related programs, policies, and/or procedures; (4) provides leadership
and coordination in planning and implementation for internal
emergencies; and (5) provides leadership and coordination in planning
and implementation for internal emergency incidents affecting the CDC
facilities, including incident response and support.
James D. Seligman,
Acting Chief Operating Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2015-00146 Filed 1-8-15; 8:45 am]
BILLING CODE 4160-18-P
